Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_assertion type Assertion NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_head.
- NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_assertion wasGeneratedBy ECO_0000203 NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_provenance.
- NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_assertion wasDerivedFrom befree-20150227 NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_provenance.
- NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_assertion SIO_000772 20971509 NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_provenance.
- NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_assertion evidence source_evidence_literature NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_provenance.
- NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_assertion description "[In conclusion, bortezomib used alone in MDS shows modest hematologic efficacy but appears to affect the WT1 gene expression, which is typically increased in these diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778253.RAAJgQ1ncUb0WcCY2T3B6AOSIPpZszAvfV3so9likvbXg130_provenance.